HEALTHCARE INVESTMENT BANKING

Lucid’s vision helps bring certainty to the dynamic healthcare markets

OVERVIEW

Healthcare Banking

Our healthcare investment banking franchise works by delivering a process-oriented approach for each client’s needs. By developing a bespoke solution, whether it be through navigating the capital markets or exploring strategic alternatives, our clients can be certain that Lucid will put their best interest in mind and will not stop working until they are satisfied.

MEET THE TEAM

Leadership

Lucid’s senior healthcare team has worked together directly over the past 15 years - developing a distinct approach producing effective results

David Strupp
Managing Director, Co-Head of Healthcare Investment Banking

  • David is a managing director and Co-Head of the Healthcare Investment Banking Group at Lucid Capital Markets. David has over 30 years of dedicated healthcare investment banking experience. During his career, David has completed numerous transactions across a range of products, including M&A advisory, equity and equity-linked offerings, private placements and fixed income transactions, totaling over $40 billion in transaction value. David began his career on Wall Street working in the healthcare groups at UBS, Montgomery Securities and Citigroup. More recently, David has worked as a senior member of the healthcare groups at boutique investment banks, including Ladenburg Thalmann, ThinkEquity and Canaccord. David received a BA in Economics from Bates College and an MSc in Economics from the London School of Economics

Vlad Ivanov
Managing Director, Co-Head of Healthcare Investment Banking

  • Vlad currently serves as Managing Director & Co-Head of Healthcare Investment Banking for Lucid Capital Markets. Vlad has over 15 years of investment banking and capital markets experience, and previously served as Managing Director in the Healthcare Investment Banking group at Ladenburg Thalmann. Over his career, Vlad has worked with numerous life sciences companies assisting them in a broad cross-section of transaction types, including M&A advisory, equity and equity-linked offerings, private placements and fixed income transactions. Vlad has completed over 30 strategic transactions as well as over 350 financing transactions in his career, raising in excess of $11 billion. Vlad holds a bachelor’s degree in Business Administration, with a concentration is Financial Analysis, from the University at Albany.

Cameron Gray
Managing Director

  • Cameron recently joined Lucid as Managing Director and brings over ten years of investment banking experience to Lucid, with a specialized focus in biotechnology and life sciences. Cameron joins Lucid from Paulson Investment Company, where he served as Managing Director. Prior to Paulson, Cameron held similar positions at National Securities and MDB Capital Group. Before his investment banking career, Cameron previously served as Senior Vice President at ICAP Patent Brokerage, LLC. He earned his Ph.D. in biophysics from the University of Virginia, his J.D. from George Washington University School of Law, and his B.A. in physics from Princeton University.

SERVICES

Areas of expertise

Capital Markets

Leveraging expertise in healthcare capital markets, we strategically connect public and private clients with the right institutional investors. Our commitment is to deliver high-quality advisory services that ensure each partnership is both meaningful and results-driven

Mergers & Acquisitions

With decades of experience, our team has established itself as a leader in small-to-mid cap life science M&A. We provide comprehensive guidance throughout the entire transaction lifecycle, from initial strategy development to deal execution and post-transaction integration. Our approach is deeply client-focused, ensuring each transaction is tailored to meet the unique needs and objectives of our clients

Financial Advisory

We provide specialized financial advisory services, offering strategic guidance on restructuring, recapitalization, and valuation. Our customized analyses empower clients to navigate complex financial decisions, equipping them with the insights needed to overcome challenges and capitalize on new opportunities

Our senior healthcare banking team has worked together on the execution of over:

500+

Financing Transactions

$2.5B

in Gross Proceeds Raised

40+

Strategic M&A Transactions